Unsupervised Deep Learning for Synthetic CT Generation from CBCT Images for Proton and Carbon Ion Therapy for Paediatric Patients.

Journal: Sensors (Basel, Switzerland)
PMID:

Abstract

Image-guided treatment adaptation is a game changer in oncological particle therapy (PT), especially for younger patients. The purpose of this study is to present a cycle generative adversarial network (CycleGAN)-based method for synthetic computed tomography (sCT) generation from cone beam CT (CBCT) towards adaptive PT (APT) of paediatric patients. Firstly, 44 CBCTs of 15 young pelvic patients were pre-processed to reduce ring artefacts and rigidly registered on same-day CT scans (i.e., verification CT scans, vCT scans) and then inputted to the CycleGAN network (employing either Res-Net and U-Net generators) to synthesise sCT. In particular, 36 and 8 volumes were used for training and testing, respectively. Image quality was evaluated qualitatively and quantitatively using the structural similarity index metric (SSIM) and the peak signal-to-noise ratio (PSNR) between registered CBCT (rCBCT) and vCT and between sCT and vCT to evaluate the improvements brought by CycleGAN. Despite limitations due to the sub-optimal input image quality and the small field of view (FOV), the quality of sCT was found to be overall satisfactory from a quantitative and qualitative perspective. Our findings indicate that CycleGAN is promising to produce sCT scans with acceptable CT-like image texture in paediatric settings, even when CBCT with narrow fields of view (FOV) are employed.

Authors

  • Matteo Pepa
    Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Siavash Taleghani
    Department of Electronics, Information and Bioengineering, Politecnico di Milano (POLIMI), 20133 Milan, Italy.
  • Giulia Sellaro
    Bioengineering Unit, Clinical Department, CNAO National Centre for Oncological Hadrontherapy, 27100 Pavia, Italy.
  • Alfredo Mirandola
    Medical Physics Unit, Clinical Department, CNAO National Centre for Oncological Hadrontherapy, 27100 Pavia, Italy.
  • Francesca Colombo
    Radiation Oncology Unit, Clinical Department, CNAO National Centre for Oncological Hadrontherapy, 27100 Pavia, Italy.
  • Sabina Vennarini
    Paediatric Radiotherapy Unit, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), 20133 Milan, Italy.
  • Mario Ciocca
    Medical Physics Unit, Clinical Department, CNAO National Centre for Oncological Hadrontherapy, 27100 Pavia, Italy.
  • Chiara Paganelli
    Dipartimento di Elettronica, Informazione e Bioingegneria, Politecnico di Milano, Milano, Italy.
  • Ester Orlandi
    Radiation Oncology Unit, Clinical Department, CNAO National Center for Oncological Hadrontherapy, Pavia, Italy; Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
  • Guido Baroni
    Department of Electronics, Information and Bioengineering, Politecnico di Milano (POLIMI), 20133 Milan, Italy.
  • Andrea Pella
    Bioengineering Unit, Clinical Department, CNAO National Centre for Oncological Hadrontherapy, 27100 Pavia, Italy.